Re: New pill from Pfizer....
|
5
|
Resverlogix Corp.
|
Mar 23, 2021 05:43PM
|
Re: A Second Publication Shortlists Resverlogix Clinical Candidate Apabetalone for its Potential COVID-19 Effectiveness Including Reducing Cytokine Storms
|
5
|
Resverlogix Corp.
|
Oct 26, 2020 03:59PM
|
Re: when might we expect the first update on the trial?
|
5
|
Resverlogix Corp.
|
Jun 01, 2021 11:11AM
|
Re: AHA late breaking abstract
|
5
|
Resverlogix Corp.
|
Nov 10, 2019 04:15PM
|
Re: Just back from IR,...
|
5
|
Resverlogix Corp.
|
Oct 26, 2019 05:39AM
|
Re: Obesity
|
5
|
Resverlogix Corp.
|
Aug 11, 2020 07:16PM
|
Re: Wow! Quite the read!
|
5
|
Resverlogix Corp.
|
May 29, 2021 06:32PM
|
Re: Comments on the AGM
|
5
|
Resverlogix Corp.
|
Nov 11, 2019 04:54AM
|
Re: Wow! Quite the read!
|
5
|
Resverlogix Corp.
|
May 29, 2021 06:37PM
|
Re: Estimated Glomerular Filtration Rate
|
5
|
Resverlogix Corp.
|
Nov 17, 2019 05:51PM
|
Re: Update from IR -- Eversana paused?
|
5
|
Resverlogix Corp.
|
Dec 20, 2022 12:50AM
|
NFK meeting
|
5
|
Resverlogix Corp.
|
Feb 19, 2020 03:26PM
|
Re: so what happens if dm fumbles the ball??
|
5
|
Resverlogix Corp.
|
Jul 12, 2020 07:35PM
|
Re: eGFR data question from IR
|
5
|
Resverlogix Corp.
|
Nov 28, 2019 08:22AM
|
Re: Don's latest presentation
|
5
|
Resverlogix Corp.
|
Sep 22, 2020 12:46PM
|
Re: Bear
|
5
|
Resverlogix Corp.
|
Feb 26, 2020 03:32PM
|
Re: 0.05 P-values -- A bridge too far ?
|
5
|
Resverlogix Corp.
|
Feb 12, 2020 03:31PM
|
Re: 0.05 P-values -- A bridge too far ?
|
5
|
Resverlogix Corp.
|
Feb 12, 2020 03:40PM
|
Re: New Share Price Contest update to Oct 12th
|
5
|
Resverlogix Corp.
|
Oct 13, 2019 05:00PM
|
Re: Clarification on BETonMACE baseline data
|
5
|
Resverlogix Corp.
|
Sep 05, 2019 10:00AM
|